EpiVax participated in the 2021 International Society for Vaccines (ISV) Annual Virtual Congress September 13-15, 2021.
The 2021 Congress was a busy one, it’s been a difficult but innovative period for the vaccine development community.
Multiple EpiVax scientists presented throughout the three-day event, details below!
EpiVax Director of Vaccine Research, Dr. Lenny Moise, co-chaired the Plenary Session 2 alongside Amy Epeseth from Merck.
Dr. Michael Princiotta, CSO of EpiVax Therapeutics, presented Efficient Selection of Tumor Associated neoantigens in the Design of Personal Vaccines” during the first Plenary Session on Monday, September 13th. Watch the talk below!
The EpiVax Vaccine Team presented several posters during the ISV Poster session. Check them out below!
And to round out the event, ISV Fellow and EpiVax CEO/CSO Dr. Annie De Groot participated in the Meet the Fellows session on Wednesday, September 15th!